Grants and Contributions:
Title:
820313
Agreement Number:
820313
Agreement Value:
$79,000,000.00
Agreement Date:
Jan 9, 2026 - Jul 31, 2050
Description:
This project will commercialize bioprinted tissue therapeutics, expand AI-enabled bioprinting and cell engineering capabilities, and establish a commercial-scale Current Good Manufacturing Practice biomanufacturing facility with end-to-end automation. The project’s work phase is scheduled to end on March 31, 2031.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The results of the project include the completed construction and commissioning of a Current Good Manufacturing Practice biomanufacturing facility, develop a skilled workforce and implement a validated processes for production.
Location:
Vancouver, British Columbia, CA V5Y 0N7
Reference Number:
033-2025-2026-Q4-820313
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
830167839
Recipient Type:
For-profit organization
Recipient's Operating Name:
Aspect Biosystems
Recipient's Legal Name:
Aspect Biosystems Ltd.
Federal Riding Name:
Vancouver Granville
Federal Riding Number:
59036
Program:
SIF Stream 2- Growth
Program Purpose:
Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services; Facilitate the growth and expansion of firms in Canada; Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
325410